The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Morphology-predicted, large-scale transition (LST) number in circulating tumor cells (CTC) as a biomarker of chromosomal instability (CIN) to assess early resistance to standard of care (SOC) drugs in mCRPC.

Howard I.  Scher

Leadership - Asterias Biotherapeutics

Stock and Other Ownership Interests  - Asterias Biotherapeutics

Consulting or Advisory Role - Ambry Genetics/Konica Minolta; Janssen; Janssen Research & Development; OncLive Insights; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group

Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst)

Travel, Accommodations, Expenses - Asterias Biotherapeutics; OncLive Insights; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group

Joseph  Schonhoft

Employment - Epic Sciences

Stock and Other Ownership Interests  - Epic Sciences

Melanie  Hullings

No Relationships to Disclose

Emily  Carbone

No Relationships to Disclose

Ethan  Barnett

No Relationships to Disclose

Ramsay  Sutton

Employment - Epic Sciences

Stock and Other Ownership Interests  - Epic Sciences

Adam  Jendrisak

Employment - Epic Sciences

Stock and Other Ownership Interests  - Epic Sciences

Research Funding - Epic Sciences

Mark Andrew  Landers

Employment - Epic Sciences

Stock and Other Ownership Interests  - Epic Sciences

Patents, Royalties, Other Intellectual Property - Epic Sciences

Yipeng  Wang

Employment - Epic Sciences

Stock and Other Ownership Interests  - Epic Sciences

Ryan  Dittamore

Employment - Epic Sciences

Leadership - Epic Sciences

Stock and Other Ownership Interests  - Epic Sciences

Patents, Royalties, Other Intellectual Property - Patents Pending